Skip to main content
. 2018 Sep 26;14(9):e1007679. doi: 10.1371/journal.pgen.1007679

Fig 1. PBRM1 downregulation has no effect on growth inhibition by rapamycin in the ccRCC line 786-O.

Fig 1

(A) PBRM1 expression in 786-O cells stably expressing different PBRM1 shRNAs was assessed by immunoblotting. (B) 786-O cells stably expressing control shRNAs or PBRM1 shRNAs 889, 890 and 994 were treated with DMSO or 20nM rapamycin (RAPA) for 24, 48 and 72hr. Cell number was quantified using Crystal Violet, and normalized to day 1 (24 hr).